News Detail
![](pdf/sbl_insulin160624175907.jpg)
NEW DELHI, 16 JUNE 2024: Despite clear directions from India's drug regulator, the Ayush Ministry and the Rajasthan government have yet to act against a pharma company selling a homoeopathic medicine named ‘insulin’.
The Rajasthan-based company ......
View Details
Source : The New Indian Express
insulin
homoeopathic drug
Related News
- DCA Seizes Overpriced, misleading claim Medicine (26-06-2024)
- Inquiry demanded at Maharashtra Assembly on export nod for over 200 pharma companies without stability testing (26-06-2024)
- Spurious drug factory busted in Gandhinagar (26-06-2024)
- Gang involved in illegal drug trade busted; 11 arrested (26-06-2024)
- 90% of healthcare companies get a 'B+' on cybersecurity with medical devices (26-06-2024)
- US lawmakers questions FDAs drug inspection programme in India and China (25-06-2024)
- Two arrested with 36,000 bottles of banned cough syrup in Siliguri (25-06-2024)
- DoP further expands list of special invitees into committee constituted to reform pricing framework (25-06-2024)
- India key market for APIs, but patients forced to cough up crores to buy orphan drugs (25-06-2024)
- Govt considers ban on two antibiotics for poultry and animal feed supplements (25-06-2024)